Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: TP53, . Treffer: 67

2023

Alcaniz, J; Winkler, L; Dahlmann, M; Becker, M; Orthmann, A; Haybaeck, J; Krassnig, S; Skofler, C; Kratzsch, T; Kuhn, SA; Jödicke, A; Linnebacher, M; Fichtner, I; Walther, W; Hoffmann, J Clinically relevant glioblastoma patient-derived xenograft models to guide drug development and identify molecular signatures.
Front Oncol. 2023; 13: 1129627 Doi: 10.3389/fonc.2023.1129627 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Dai, Q; Zhang, J; Long, W; Haybaeck, J; Yang, Z Genetic alterations of GI-NECs involving three main signaling pathways.
Cancer Med. 2023; Doi: 10.1002/cam4.5633 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Webersinke, G; Burghofer, J; Malli, T; Rammer, M; Jahn, SW; Niendorf, A; Tavassoli, FA; Moinfar, F TERT Promoter Mutation c.-124C>T Commonly Occurs in Low-Grade Fibromatosis-like Metaplastic Breast Carcinoma.
Arch Pathol Lab Med. 2023; Doi: 10.5858/arpa.2022-0159-OA
PubMed FullText FullText_MUG

 

2022

Dutta, S; Moritz, J; Pregartner, G; Thallinger, GG; Brandstätter, I; Lind, K; Rezania, S; Lyssy, F; Reinisch, A; Zebisch, A; Berghold, A; Wölfler, A; Sill, H Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations.
Ann Hematol. 2022; 101(4):837-846 Doi: 10.1007/s00277-022-04766-2 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Feng, J; Li, Y; Wei, B; Guo, L; Li, W; Xia, Q; Zhao, C; Zheng, J; Zhao, J; Sun, R; Guo, Y; Brcic, L; Hakozaki, T; Ying, J; Ma, J Clinicopathologic characteristics and diagnostic methods of RET rearrangement in Chinese non-small cell lung cancer patients.
Transl Lung Cancer Res. 2022; 11(4): 617-631. Doi: 10.21037/tlcr-22-202 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Illini, O; Fabikan, H; Hochmair, MJ; Weinlinger, C; Krenbek, D; Brcic, L; Setinek, U; Terbuch, A; Absenger, G; Konjić, S; Valipour, A Characteristics and Treatment Outcomes in Advanced-Stage Non-Small Cell Lung Cancer Patients with a KRAS G12C Mutation: A Real-World Study.
J Clin Med. 2022; 11(14): Doi: 10.3390/jcm11144098 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Meinhardt, AL; Munkhbaatar, E; Höckendorf, U; Dietzen, M; Dechant, M; Anton, M; Jacob, A; Steiger, K; Weichert, W; Brcic, L; McGranahan, N; Branca, C; Kaufmann, T; Dengler, MA; Jost, PJ The BCL-2 family member BOK promotes KRAS-driven lung cancer progression in a p53-dependent manner.
Oncogene. 2022; 41(9):1376-1382 Doi: 10.1038/s41388-021-02161-1 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Penkert, J; Strüwe, FJ; Dutzmann, CM; Doergeloh, BB; Montellier, E; Freycon, C; Keymling, M; Schlemmer, HP; Sänger, B; Hoffmann, B; Gerasimov, T; Blattmann, C; Fetscher, S; Frühwald, M; Hettmer, S; Kordes, U; Ridola, V; Kroiss, Benninger, S; Mastronuzzi, A; Schott, S; Nees, J; Prokop, A; Redlich, A; Seidel, MG; Zimmermann, S; Pajtler, KW; Pfister, SM; Hainaut, P; Kratz, CP Genotype-phenotype associations within the Li-Fraumeni spectrum: a report from the German Registry.
J Hematol Oncol. 2022; 15(1): 107 Doi: 10.1186/s13045-022-01332-1 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Regauer, S; Reich, O; Kashofer, K HPV-negative Squamous Cell Carcinomas of the Cervix With Special Focus on Intraepithelial Precursor Lesions.
AM J SURG PATHOL. 2022; 46(2): 147-158. Doi: 10.1097/PAS.0000000000001778
Web of Science PubMed FullText FullText_MUG

 

Wicik, Z; Czajka, P; Eyileten, C; Fitas, A; Wolska, M; Jakubik, D; von, Lewinski, D; Sourij, H; Siller-Matula, JM; Postula, M The role of miRNAs in regulation of platelet activity and related diseases - a bioinformatic analysis.
Platelets. 2022; 33(7): 1052-1064. Doi: 10.1080/09537104.2022.2042233
Web of Science PubMed FullText FullText_MUG

 

Wirth, AK; Wange, L; Vosberg, S; Henrich, KO; Rausch, C; Özdemir, E; Zeller, CM; Richter, D; Feuchtinger, T; Kaller, M; Hermeking, H; Greif, PA; Senft, D; Jurinovic, V; Bahrami, E; Jayavelu, AK; Westermann, F; Mann, M; Enard, W; Herold, T; Jeremias, I In vivo PDX CRISPR/Cas9 screens reveal mutual therapeutic targets to overcome heterogeneous acquired chemo-resistance.
Leukemia. 2022; 36(12):2863-2874 Doi: 10.1038/s41375-022-01726-7 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2021

Aftimos, P; Oliveira, M; Irrthum, A; Fumagalli, D; Sotiriou, C; Gal-Yam, EN; Robson, ME; Ndozeng, J; Di, Leo, A; Ciruelos, EM; de, Azambuja, E; Viale, G; Scheepers, ED; Curigliano, G; Bliss, JM; Reis-Filho, JS; Colleoni, M; Balic, M; Cardoso, F; Albanell, J; Duhem, C; Marreaud, S; Romagnoli, D; Rojas, B; Gombos, A; Wildiers, H; Guerrero-Zotano, A; Hall, P; Bonetti, A; Larsson, KF; Degiorgis, M; Khodaverdi, S; Greil, R; Sverrisdóttir, Á; Paoli, M; Seyll, E; Loibl, S; Linderholm, B; Zoppoli, G; Davidson, NE; Johannsson, OT; Bedard, PL; Loi, S; Knox, S; Cameron, DA; Harbeck, N; Montoya, ML; Brandão, M; Vingiani, A; Caballero, C; Hilbers, FS; Yates, LR; Benelli, M; Venet, D; Piccart, MJ Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative.
Cancer Discov. 2021; 11(11): 2796-2811. Doi: 10.1158/2159-8290.CD-20-1647 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Fan, K; Spassova, I; Gravemeyer, J; Ritter, C; Horny, K; Lange, A; Gambichler, T; Ødum, N; Schrama, D; Schadendorf, D; Ugurel, S; Becker, JC Merkel cell carcinoma-derived exosome-shuttle miR-375 induces fibroblast polarization by inhibition of RBPJ and p53.
Oncogene. 2021; 40(5):980-996 Doi: 10.1038/s41388-020-01576-6 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Middeke, JM; Teipel, R; Röllig, C; Stasik, S; Zebisch, A; Sill, H; Kramer, M; Scholl, S; Hochhaus, A; Jost, E; Brümmendorf, TH; Naumann, R; Steffen, B; Serve, H; Altmann, H; Kunzmann, V; Einsele, H; Parmentier, S; Schaich, M; Burchert, A; Neubauer, A; Schliemann, C; Berdel, WE; Sockel, K; Stölzel, F; Platzbecker, U; Ehninger, G; Bornhäuser, M; Schetelig, J; Thiede, C, , Study, Alliance, Leukemia, (SAL) Decitabine treatment in 311 patients with acute myeloid leukemia: outcome and impact of TP53 mutations - a registry based analysis.
Leuk Lymphoma. 2021; 62(6):1432-1440 Doi: 10.1080/10428194.2020.1864354
Web of Science PubMed FullText FullText_MUG

 

Popper, H; Brcic, L Diagnosis and Molecular Profiles of Large Cell Neuroendocrine Carcinoma With Potential Targets for Therapy.
FRONT ONCOL. 2021; 11: 655752 Doi: 10.3389/fonc.2021.655752 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Scheipl, S; Brcic, I; Moser, T; Fischerauer, S; Riedl, J; Bergovec, M; Smolle, M; Posch, F; Gerger, A; Pichler, M; Stoeger, H; Leithner, A; Heitzer, E; Liegl-Atzwanger, B; Szkandera, J Molecular profiling of soft-tissue sarcomas with FoundationOne® Heme identifies potential targets for sarcoma therapy: a single-centre experience.
Ther Adv Med Oncol. 2021; 13:17588359211029125 Doi: 10.1177/17588359211029125 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Schneider, R; Gademann, G; Ochel, HJ; Neumann, K; Jandrig, B; Hass, P; Walke, M; Schostak, M; Brunner, T; Christoph, F Functional and mutational analysis after radiation and cetuximab treatment on prostate carcinoma cell line DU145.
Radiat Oncol. 2021; 16(1): 137 Doi: 10.1186/s13014-021-01859-6 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Thijssen, R; Diepstraten, ST; Moujalled, D; Chew, E; Flensburg, C; Shi, MX; Dengler, MA; Litalien, V; MacRaild, S; Chen, M; Anstee, NS; Reljić, B; Gabriel, SS; Djajawi, TM; Riffkin, CD; Aubrey, BJ; Chang, C; Tai, L; Xu, Z; Morley, T; Pomilio, G; Bruedigam, C; Kallies, A; Stroud, DA; Bajel, A; Kluck, RM; Lane, SW; Schoumacher, M; Banquet, S; Majewski, IJ; Strasser, A; Roberts, AW; Huang, DCS; Brown, FC; Kelly, GL; Wei, AH Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias.
Blood. 2021; 137(20): 2721-2735. Doi: 10.1182/blood.2020010167 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Zalyte, E; Dedonyte, V; Kurlinkus, B; Sileikis, A; Schemmer, P; Valius, M Establishment and Characterization of a New Pancreatic Ductal Adenocarcinoma Cell Line Capan-26.
ANTICANCER RES. 2021; 41(3): 1401-1406. Doi: 10.21873/anticanres.14897
Web of Science PubMed FullText FullText_MUG

 

2020

Brodowicz, T; Liegl-Atzwanger, B; Penel, N; Mir, O; Blay, JY; Kashofer, K; Le Cesne, A; Decoupigny, E; Wallet, J; Hamacher, R; Deley, ML Assessing Prognostic and Predictive Biomarkers of Regorafenib Response in Patients with Advanced Soft Tissue Sarcoma: REGOSARC Study.
Cancers (Basel). 2020; 12(12): Doi: 10.3390/cancers12123746 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Dutta, S; Pregartner, G; Rücker, FG; Heitzer, E; Zebisch, A; Bullinger, L; Berghold, A; Döhner, K; Sill, H Functional Classification of TP53 Mutations in Acute Myeloid Leukemia.
Cancers (Basel). 2020; 12(3): Doi: 10.3390/cancers12030637 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Lampignano, R; Neumann, MHD; Weber, S; Kloten, V; Herdean, A; Voss, T; Groelz, D; Babayan, A; Tibbesma, M; Schlumpberger, M; Chemi, F; Rothwell, DG; Wikman, H; Galizzi, J-P; Bergheim, IR; Russnes, H; Mussolin, B; Bonin, S; Voight, C; Musa, H; Pinzani, P; Lianidou, E; Brady, G; Speicher, MR; Pantel, K; Betsou, F, Schuuring, E; Kubista, M; Ammerlaan, W; Sprenger-Haussels, M; Schlange, T; Heitzer, E Multicenter Evaluation of Circulating Cell-Free DNA Extraction and Downstream Analyses for the Development of Standardized (Pre)analytical Work Flows
The Open Clinical Chemistry Journal. 2020; 66(1): 149-160. Doi: 10.1373/clinchem.2019.306837 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Munkhbaatar, E; Dietzen, M; Agrawal, D; Anton, M; Jesinghaus, M; Boxberg, M; Pfarr, N; Bidola, P; Uhrig, S; Höckendorf, U; Meinhardt, AL; Wahida, A; Heid, I; Braren, R; Mishra, R; Warth, A; Muley, T; Poh, PSP; Wang, X; Fröhling, S; Steiger, K; Slotta-Huspenina, J; van, Griensven, M; Pfeiffer, F; Lange, S; Rad, R; Spella, M; Stathopoulos, GT; Ruland, J; Bassermann, F; Weichert, W; Strasser, A; Branca, C; Heikenwalder, M; Swanton, C; McGranahan, N; Jost, PJ MCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeutically.
Nat Commun. 2020; 11(1):4527 Doi: 10.1038/s41467-020-18372-1 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Sill, H; Zebisch, A; Haase, D Acute Myeloid Leukemia and Myelodysplastic Syndromes with TP53 Aberrations - A Distinct Stem Cell Disorder.
Clin Cancer Res. 2020; 26(20):5304-5309 Doi: 10.1158/1078-0432.CCR-20-2272 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2019

Brcic, L; Kuchler, C; Eidenhammer, S; Pabst, D; Quehenberger, F; Gazdar, AF; Popper, H Comparison of four DLL3 antibodies performance in high grade neuroendocrine lung tumor samples and cell cultures.
Diagn Pathol. 2019; 14(1): 47-47. Doi: 10.1186/s13000-019-0827-z [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kunc, M; Gabrych, A; Rekawiecki, B; Gorczynski, A; Franke, S; Haybaeck, J; Biernat, W; Czapiewski, P MLH1 promoter hypermethylation in uterine carcinosarcoma rarely coexists with TP53 mutation.
Contemp Oncol (Pozn). 2019; 23(4): 202-207. Doi: 10.5114/wo.2019.89635 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Pichler, R; Compérat, E; Klatte, T; Pichler, M; Loidl, W; Lusuardi, L; Schmidinger, M Renal Cell Carcinoma with Sarcomatoid Features: Finally New Therapeutic Hope?
Cancers (Basel). 2019; 11(3): 422 Doi: 10.3390/cancers11030422 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Prochazka, KT; Pregartner, G; Rücker, FG; Heitzer, E; Pabst, G; Wölfler, A; Zebisch, A; Berghold, A; Döhner, K; Sill, H Clinical implications of subclonal TP53 mutations in acute myeloid leukemia.
Haematologica. 2019; 104(3):516-523 Doi: 10.3324/haematol.2018.205013 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Regauer, S; Kashofer, K; Reich, O Time series analysis of TP53 gene mutations in recurrent HPV-negative vulvar squamous cell carcinoma
MODERN PATHOL. 2019; 32(3): 415-422. Doi: 10.1038/s41379-018-0141-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2018

Al-Zoughbi, W; Schauer, S; Pichler, M; Hoefler, G Early Loss of Forkhead Transcription Factor, O Subgroup, Member 1 Protein in the Development of Pancreatic Ductal Adenocarcinoma.
Pathobiology. 2018; 85(5-6): 342-347. Doi: 10.1159/000492433 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Griewank, KG; Wiesner, T; Murali, R; Pischler, C; Müller, H; Koelsche, C; Möller, I; Franklin, C; Cosgarea, I; Sucker, A; Schadendorf, D; Schaller, J; Horn, S; Brenn, T; Mentzel, T Atypical fibroxanthoma and pleomorphic dermal sarcoma harbor frequent NOTCH1/2 and FAT1 mutations and similar DNA copy number alteration profiles.
Mod Pathol. 2018; 31(3): 418-428. Doi: 10.1038/modpathol.2017.146 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Hofving, T; Arvidsson, Y; Almobarak, B; Inge, L; Pfragner, R; Persson, M; Stenman, G; Kristiansson, E; Johanson, V; Nilsson, O The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines.
ENDOCR-RELAT CANCER. 2018; 25(3): 367-380. Doi: 10.1530/ERC-17-0445 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kindler, O; Quehenberger, F; Benesch, M; Seidel, MG The Iceberg Map of germline mutations in childhood cancer: focus on primary immunodeficiencies.
Curr Opin Pediatr. 2018; 30(6):855-863 Doi: 10.1097/MOP.0000000000000680
Web of Science PubMed FullText FullText_MUG

 

Reidel, V; Kauschinger, J; Hauch, RT; Müller-Thomas, C; Nadarajah, N; Burgkart, R; Schmidt, B; Hempel, D; Jacob, A; Slotta-Huspenina, J; Höckendorf, U; Peschel, C; Kern, W; Haferlach, T; Götze, KS; Jilg, S; Jost, PJ Selective inhibition of BCL-2 is a promising target in patients with high-risk myelodysplastic syndromes and adverse mutational profile.
Oncotarget. 2018; 9(25):17270-17281 Doi: 10.18632/oncotarget.24775 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

Schulz, E; Lind, K; Renner, W; Petersen, BS; Quehenberger, F; Dill, C; Hofer, S; Lal, R; Hoefler, G; Schlenke, P; Ehninger, G; Schetelig, J; Middeke, JM; Stölzel, F; Sill, H The TP53 Pro72Arg SNP in de novo acute myeloid leukaemia - results of two cohort studies involving 215 patients and 3759 controls.
Br J Haematol. 2018; 181(1):148-151 Doi: 10.1111/bjh.14527 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2017

González-Vela, MDC; Curiel-Olmo, S; Derdak, S; Beltran, S; Santibañez, M; Martínez, N; Castillo-Trujillo, A; Gut, M; Sánchez-Pacheco, R; Almaraz, C; Cereceda, L; Llombart, B; Agraz-Doblas, A; Revert-Arce, J; López Guerrero, JA; Mollejo, M; Marrón, PI; Ortiz-Romero, P; Fernandez-Cuesta, L; Varela, I; Gut, I; Cerroni, L; Piris, MÁ; Vaqué, JP Shared Oncogenic Pathways Implicated in Both Virus-Positive and UV-Induced Merkel Cell Carcinomas.
J Invest Dermatol. 2017; 137(1):197-206 Doi: 10.1016/j.jid.2016.08.015 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Heitzer, E; Sunitsch, S; Gilg, MM; Lohberger, B; Rinner, B; Kashofer, K; Stündl, N; Ulz, P; Szkandera, J; Leithner, A; Liegl-Atzwanger, B Expanded molecular profiling of myxofibrosarcoma reveals potentially actionable targets.
Mod Pathol. 2017; 30(12):1698-1709 Doi: 10.1038/modpathol.2017.94 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kashofer, K; Regauer, S Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy.
GYNECOL ONCOL. 2017; 146(2): 314-318. Doi: 10.1016/j.ygyno.2017.05.018
Web of Science PubMed FullText FullText_MUG

 

Kashofer, K; Winter, E; Halbwedl, I; Thueringer, A; Kreiner, M; Sauer, S; Regauer, S HPV-negative penile squamous cell carcinoma: disruptive mutations in the TP53 gene are common.
Mod Pathol. 2017; 30(7):1013-1020 Doi: 10.1038/modpathol.2017.26 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Lohberger, B; Stuendl, N; Leithner, A; Rinner, B; Sauer, S; Kashofer, K; Liegl-Atzwanger, B Establishment of a novel cellular model for myxofibrosarcoma heterogeneity.
Sci Rep. 2017; 7(9):44700-44700 Doi: 10.1038/srep44700 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Weyerer, V; Schneckenpointner, R; Filbeck, T; Burger, M; Hofstaedter, F; Wild, PJ; Fine, SW; Humphrey, PA; Dehner, LP; Amin, MB; Rüschoff, J; Boltze, C; Tannapfel, A; Zwarthoff, E; Lopez-Beltran, A; Montironi, R; Langner, C; Stoehr, R; Hartmann, A; Giedl, J Immunohistochemical and molecular characterizations in urothelial carcinoma of bladder in patients less than 45 years.
J Cancer. 2017; 8(3):323-331 Doi: 10.7150/jca.17482 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Woischke, C; Schaaf, CW; Yang, HM; Vieth, M; Veits, L; Geddert, H; Märkl, B; Stömmer, P; Schaeffer, DF; Frölich, M; Blum, H; Vosberg, S; Greif, PA; Jung, A; Kirchner, T; Horst, D In-depth mutational analyses of colorectal neuroendocrine carcinomas with adenoma or adenocarcinoma components.
Mod Pathol. 2017; 30(1): 95-103. Doi: 10.1038/modpathol.2016.150
Web of Science PubMed FullText FullText_MUG

 

2016

Fröhlich, LF; Mrakovcic, M; Smole, C; Zatloukal, K Molecular mechanism leading to SAHA-induced autophagy in tumor cells: evidence for a p53-dependent pathway.
Cancer Cell Int. 2016; 16(1):68-68 Doi: 10.1186/s12935-016-0343-0 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Lax, SF [New features in the 2014 WHO classification of uterine neoplasms].
Pathologe. 2016; 37(6):500-511 Doi: 10.1007/s00292-016-0230-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Fischer, C; Scheipl, S; Zopf, A; Niklas, N; Deutsch, A; Jorgensen, M; Lohberger, B; Froehlich, EV; Leithner, A; Gabriel, C; Liegl-Atzwanger, B; Rinner, B Mutation Analysis of Nine Chordoma Specimens by Targeted Next-Generation Cancer Panel Sequencing.
J Cancer. 2015; 6(10):984-989 Doi: 10.7150/jca.11371 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Jahn, SW; Kashofer, K; Halbwedl, I; Winter, G; El-Shabrawi-Caelen, L; Mentzel, T; Hoefler, G; Liegl-Atzwanger, B Mutational dichotomy in desmoplastic malignant melanoma corroborated by multigene panel analysis.
Mod Pathol. 2015; 28(7):895-903 Doi: 10.1038/modpathol.2015.39 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kandioler, D; Mittlböck, M; Kappel, S; Puhalla, H; Herbst, F; Langner, C; Wolf, B; Tschmelitsch, J; Schippinger, W; Steger, G; Hofbauer, F; Samonigg, H; Gnant, M; Teleky, B; Kührer, I; p53 Research Group and the Austrian Breast and Colorectal Study Group (ABCSG) TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer Patients.
EBioMedicine. 2015; 2(8):825-830 Doi: 10.1016/j.ebiom.2015.06.003 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kovac, M; Blattmann, C; Ribi, S; Smida, J; Mueller, NS; Engert, F; Castro-Giner, F; Weischenfeldt, J; Kovacova, M; Krieg, A; Andreou, D; Tunn, PU; Dürr, HR; Rechl, H; Schaser, KD; Melcher, I; Burdach, S; Kulozik, A; Specht, K; Heinimann, K; Fulda, S; Bielack, S; Jundt, G; Tomlinson, I; Korbel, JO; Nathrath, M; Baumhoer, D Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency.
Nat Commun. 2015; 6: 8940 Doi: 10.1038/ncomms9940 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Murali, R; Chandramohan, R; Möller, I; Scholz, SL; Berger, M; Huberman, K; Viale, A; Pirun, M; Socci, ND; Bouvier, N; Bauer, S; Artl, M; Schilling, B; Schimming, T; Sucker, A; Schwindenhammer, B; Grabellus, F; Speicher, MR; Schaller, J; Hillen, U; Schadendorf, D; Mentzel, T; Cheng, DT; Wiesner, T; Griewank, KG Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway.
Oncotarget. 2015; 6(34):36041-36052 Doi: 10.18632/oncotarget.5936 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Saternus, R; Pilz, S; Gräber, S; Kleber, M; März, W; Vogt, T; Reichrath, J A closer look at evolution: Variants (SNPs) of genes involved in skin pigmentation, including EXOC2, TYR, TYRP1, and DCT, are associated with 25(OH)D serum concentration.
Endocrinology. 2015; 156(1):39-47 Doi: 10.1210/en.2014-1238 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Weitere 50 Treffer anzeigen

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum